SCHEDULE: Armistice Capital Discloses 9.99% Stake in VSee Health

Armistice Capital, LLC and Steven Boyd have reported beneficial ownership of 9.99% of VSee Health, Inc. common stock as of March 31, 2026.

Summary

• Armistice Capital, LLC and Steven Boyd collectively hold 4,861,392 shares of VSee Health, Inc. common stock.
• This represents 9.99% of the total class of securities.
• The filing is an amendment to a previous Schedule 13G, indicating a change in reporting status or holdings.
• Armistice Capital, LLC acts as the investment manager for the Master Fund, which is the direct holder of the shares.
• Steven Boyd is the managing member of Armistice Capital, LLC.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a routine disclosure of beneficial ownership by an investment firm and does not contain operational or financial performance data.

Positives

• Armistice Capital, LLC and Steven Boyd have disclosed a significant ownership stake of 9.99% in VSee Health, Inc.
• The reporting persons have shared voting and dispositive power over 4,861,392 shares, indicating active management of their investment.

Negatives

• The Master Fund, the direct holder of the shares, disclaims beneficial ownership due to its investment management agreement with Armistice Capital, which limits its voting and disposal rights.

Risks

• The filing does not explicitly mention any risks. However, any significant ownership stake by an investment firm can introduce potential activist investor pressures or strategic shifts that may not align with current management's plans.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding VSee Health, Inc.'s future performance or strategies.

Management Comments

• Armistice Capital, LLC exercises voting and investment power over the securities of the Issuer held by the Master Fund and thus may be deemed to beneficially own the securities of the Issuer held by the Master Fund.
• Mr. Boyd, as the managing member of Armistice Capital, may be deemed to beneficially own the securities of the Issuer held by the Master Fund.
• The Master Fund specifically disclaims beneficial ownership of the securities of the Issuer directly held by it by virtue of its inability to vote or dispose of such securities as a result of its Investment Management Agreement with Armistice Capital.
• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

StockSavvy.ai notes that significant stake disclosures like this from investment firms often precede increased engagement with the company's management or board, potentially signaling a desire for strategic influence or operational changes within the telehealth and digital health sector.

Stakeholder Impact

• Shareholders: May see increased volatility or strategic shifts in the company's direction due to the significant stake held by Armistice Capital.
• Management: May face increased scrutiny or pressure from Armistice Capital regarding company strategy and performance.
• Creditors: No immediate impact is indicated, but significant strategic changes could indirectly affect the company's financial stability.

Next Steps

• Monitor future filings from Armistice Capital, LLC and Steven Boyd for any changes in their ownership stake or disclosed intentions.
• Observe VSee Health, Inc.'s strategic decisions and management commentary for potential responses to increased institutional investor interest.

Key Dates

Recommendation

The filing indicates a significant ownership stake by an investment firm, which could lead to future strategic influence. However, without further information on the firm's intentions or the company's performance, a 'hold' recommendation is prudent, suggesting investors monitor the situation for further developments.

Keywords

VSee Health, Armistice Capital, Schedule 13G, SEC Filing, Beneficial Ownership, Common Stock, Investment Management, Steven Boyd